glp 1 agonist delayed gastric emptying All patients on GLP1 agonists should be investigated with US if possible. Risk for gastric cannot be evaluated only in case of GI symptoms Reflections on the discovery GLP-1

Important Medical Disclaimer (Required) Peptide therapies discussed may not be FDA-approved for all uses

Is the product hexane-free? Yes

With a 10 mg vial reconstituted in 2 mL (5 mg/mL total), 100 mcg of each peptide equals 200 mcg total, which is 4 units on a U-100 syringe

Unlike older peptides, it does this without raising stress hormones like cortisol or prolactin

By reshaping the macrophage polarization landscape, PGI2 becomes a critical factor in ovarian cancer progression, and targeting its signaling pathway offers a potential therapeutic strategy to counteract tumor-promoting macrophage functions ( Figure 3 ) (98)